Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office Post author:Sam Post published:June 11, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like “An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III February 13, 2018 <b>oneservice AG</b>, Announces The Appointment Of <b>Stephen L. Elliott</b> As President <b>Oneservice Inc. North America</b> July 31, 2017 Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress June 19, 2017
<b>oneservice AG</b>, Announces The Appointment Of <b>Stephen L. Elliott</b> As President <b>Oneservice Inc. North America</b> July 31, 2017
Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress June 19, 2017